Projects per year
Abstract
There are over 100 autoimmune-related diseases affecting roughly 20% of
the population, most undiagnosed. Myalgic encephalomyelitis/chronic fatigue
syndrome (ME/CFS) is a chronic post-viral illness, for which immune dysregulation, autoimmunity, and virus reactivation are some of the key hypothesized mechanisms. Respecting the challenges of diagnosing such complex conditions and the limited specific therapies, this study aimed to provide insight into the complementarydisease management approaches in ME/CFS.
Methods
To achieve this aim, the guidelines of the National Institute for Health and Care Excellence (NICE, UK) on “Myalgic encephalomyelitis (or encephalopathy)/
chronic fatigue syndrome: diagnosis and management” (NICE guideline [NG206])
were reviewed and the Scopus, Web of Science (WoS), and PubMed databases were
used to identify relevant scientific articles.
Results
NICE guideline [NG206] notes that ME/CFS symptoms can be managed but
there is currently no cure, and recommends energy management (EM) as the option for managing ME/CFS. EM is a self-management strategy that includes all types of activity (cognitive, physical, emotional, and social), led by the person themselves with support from an ME/CFS specialist team. The following keyword search for “energy management” AND “myalgic encephalomyelitis / chronic fatigue syndrome” in the databases found a limited number of items: in Scopus (5), WoS (3), PubMed (5), and ‘Pacing’ was identified as a type of EM provided for ME/CFS patients. Although ‘Pacing’ has been used and studied for at least 10 years, a scoping review published in October 2023 highlighted the challenges of unambiguously evaluating this approach.
Conclusions
EM has been defined as one of the recommended disease management modalities for ME/CFS patients, but it is currently mainly expressed as a single ‘Pacing’. In
the authors’ view, there are other EM methods (such as Qigong, Yoga, and Coaching) whose potential should be explored for improving the quality of life of ME/CFS patients.
Original language | English |
---|---|
Pages | 24-25 |
Number of pages | 2 |
Publication status | Published - 9 Nov 2023 |
Event | International Conference Autoimmune Diseases: Main Problems and Solutions - Riga, Latvia Duration: 9 Nov 2023 → 10 Nov 2023 |
Conference
Conference | International Conference Autoimmune Diseases |
---|---|
Country/Territory | Latvia |
City | Riga |
Period | 9/11/23 → 10/11/23 |
Field of Science*
- 3.1 Basic medicine
- 5.4 Sociology
- 5.2 Economy and Business
- 3.3 Health sciences
Publication Type*
- 3.4. Other publications in conference proceedings (including local)
Fingerprint
Dive into the research topics of 'Complementary Disease Management Approaches in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome Patients'. Together they form a unique fingerprint.Projects
- 2 Finished
-
VirA: Reducing networking gaps between Rīga Stradiņš University (RSU) and internationally - leading counterparts in viral infection-induced autoimmunity research
Murovska, M. (Project leader), Lunga, A. (Work package leader), Doniņa, S. (Work package leader), Nora-Krūkle, Z. (Work package leader), Groma, V. (Work package leader), Krūmiņa, A. (Work package leader), Rasa-Dzelzkalēja, S. (Work package leader), Holodņuka, I. (Participant), Skuja, S. (Leading expert) & Lejnieks, A. (Other)
1/12/20 → 30/11/23
Project: EU Programmes › Horizon 2020
-
Selection of biomarkers in ME/CFS for patient stratification and treatment surveillance / optimisation
Murovska, M. (Project leader), Berķis, U. (Leading expert), Krūmiņa, A. (Expert), Svirskis, Š. (Expert), Grāvelsiņa, S. (Expert (PhD student)), Arāja, D. (Expert (PhD student)), Vilmane, A. (Expert (PhD student)), Vecvagare, K. (Expert (PhD student)), Maksimova, I. (Participant) & Vārna, V. (Participant)
1/01/20 → 30/06/23
Project: Fundamental and Applied Research Programme